0
Article Tier 2 Sign in to save

Polyethylene terephthalate nanoplastics promote gastric cancer progression by inhibiting the TNF-α/JAK1/STAT1 signaling pathway and shaping an immunosuppressive microenvironment

Original title: Polyethylene terephthalate nanoplastics promote gastric cancer progression by inhibiting the TNF-α/JAK1/STAT1 signaling pathway and shaping an immunosuppressive microenvironment

AI summary Read the abstract

Tiny plastic particles from PET plastic (commonly used in bottles and food packaging) may do more than just contaminate our bodies—new research in mice and lab-grown cells shows they can actually help stomach cancer grow faster and resist chemotherapy. These nanoplastics appear to weaken the immune system's ability to fight tumors and block a key cancer-suppressing pathway in the body. While this study was done in mice and cells rather than humans, it adds to growing evidence that chronic exposure to microplastics isn't just an environmental issue—it could be a real risk factor for cancer progression.

Polymers
Models
Study Type In vivo

Polyethylene terephthalate (PET), one of the most widely produced plastics used in food packaging, has emerged as a pervasive source of microplastic exposure in humans, with recent evidence confirming its presence in the human stomach. However, the biological consequences of PET nanoplastics (PET-NPs) on gastric carcinogenesis remain largely unexplored. In this study, we systematically investigated the effects of PET-NPs on gastric cancer progression and the underlying molecular and immunological mechanisms. PET-NPs were readily internalized by gastric cancer cells, leading to enhanced cell proliferation, migration, and resistance to Oxaliplatin, accompanied by suppression of apoptosis and immunogenic cell death. In vivo validation using a mouse subcutaneous tumor model further demonstrated that PET-NPs significantly promoted tumor growth. Integrated mechanistic analyses combining transcriptomics, network toxicology, and western blotting revealed that PET-NPs exhibited strong binding affinity to tumor necrosis factor-α (TNF-α), resulting in inhibition of the downstream JAK1/STAT1 signaling pathway. Moreover, PET-NPs profoundly remodeled the tumor immune microenvironment by promoting M2 macrophage polarization, reducing CD8+ T cell infiltration, upregulating immune checkpoint molecules TIGIT and PD-1, and suppressing key antitumor cytokines, including IFN-γ and TNF-α. Collectively, these findings demonstrate that PET-NPs act as a previously underrecognized environmental risk factor that accelerates gastric cancer progression through direct molecular interference and immune suppression, highlighting the potential public health implications of chronic microplastic exposure.

More Papers Like This

Article Tier 2

Polyethylene terephthalate micro-/nanoplastics suppress SAT1-dependent ferroptosis in triple-negative breast cancer

AI summary Read the abstract

Scientists found tiny plastic particles from PET (a common plastic used in bottles and packaging) inside human breast cancer tissue, and discovered these particles may help aggressive "triple-negative" breast cancer cells survive and grow faster. The plastic appears to block a natural cell-death process that normally helps kill off cancer cells, essentially giving tumors a survival advantage. While this research was done in cells and mice, it adds to growing evidence that the microplastics we're exposed to daily may not just be inert particles passing through our bodies, they could actively influence cancer progression.

Article Tier 2

Environmental Polyethylene Terephthalate Micro‐ and Nanoplastics Promote Clear Cell Renal Cell Carcinoma Progression Through Mitochondrial ROS‐Associated AKT/GSK3β/β‐Catenin Signaling

AI summary Read the abstract

Tiny plastic particles from PET (the plastic used in water bottles and food packaging) may fuel the growth of kidney cancer cells, according to a new study using cancer cells and mice. The researchers found these microplastics cause stress inside cell "power plants" (mitochondria), which then flips on a chain of signals that helps cancer cells grow and spread faster. While this doesn't prove microplastics cause cancer in people, it adds to growing evidence that these ubiquitous particles may not be as harmless as once thought, especially for someone already dealing with cancer.

Article Tier 2

Effects of microplastics on the colorectal tumor immune microenvironment and immunotherapy resistance via JAK–STAT–microbiota perturbation.

AI summary Read the abstract

Scientists found that microplastics—tiny plastic particles now common in our environment—can build up in colorectal (colon) tumors and make cancer immunotherapy less effective, based on studies in mice. The plastics seem to weaken the immune system's ability to find and attack cancer cells, partly by disrupting gut bacteria and blocking key immune signals. While this research was done in animals rather than people, it raises concerning questions about whether everyday plastic exposure could affect cancer treatment outcomes in humans.

Article Tier 2

Interaction of polystyrene nanoplastics and Helicobacter pylori modulates gastric cancer cellular functions and metastasis

AI summary Read the abstract

Tiny plastic particles called nanoplastics can stick to H. pylori, the stomach bacteria linked to gastric cancer, and this combo can damage stomach cancer cells in lab tests. Oddly, in mice, nanoplastics alone were worse, promoting cancer spread to the liver and lungs, showing these plastics may influence cancer behavior in complex, unpredictable ways.

Article Tier 2

Enhanced ASGR2 by microplastic exposure leads to resistance to therapy in gastric cancer

AI summary Read the abstract

Researchers fed polystyrene microplastics to mice and found that the particles accumulated in stomach tissue, where they triggered changes associated with more aggressive cancer behavior. In gastric cancer cells, microplastic exposure increased migration, induced drug resistance to multiple cancer therapies, and activated a gene called ASGR2 that appears to drive these effects. The study suggests that microplastic accumulation in the stomach may interfere with the effectiveness of cancer treatments.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper